ロード中...

CD28z CARs and Armored CARs

CD19-targeted chimeric antigen receptor (CAR) T cells are currently being tested in the clinic with very promising outcomes. However, limitations to CAR T cell therapy exist. These include lack of efficacy against some tumors, specific targeting of tumor cells without affecting normal tissue and ret...

詳細記述

保存先:
書誌詳細
出版年:Cancer J
主要な著者: Pegram, Hollie J., Park, Jae H., Brentjens, Renier J.
フォーマット: Artigo
言語:Inglês
出版事項: 2014
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4687893/
https://ncbi.nlm.nih.gov/pubmed/24667958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0000000000000034
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!